PDLIM5 and prostate carcinoma: The potential of PDLIM5 as an oncogene has been implicated in the progression of prostate cancer where its silencing leads to restrained prostate cancer colony formation and induced apoptosis, as well as confirmed inhibition of tumor growth in nude mice (Liu et al., 2017).